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0022-2836 © 2012 Elsevier Ltd. Open accRecently, the anticancer activity of human α-lactalbumin made lethal to
tumor cells (HAMLET) has been linked to its increasedmembrane afﬁnity in
vitro, at neutral pH, and ability to cause leakage relative to the inactive
native bovine α-lactalbumin (BLA) protein. In this study, atomic force
microscopy resolved membrane distortions and annular oligomers (AOs)
produced by HAMLET when deposited at neutral pH on mica together
with a negatively charged lipid monolayer. BLA, BAMLET (HAMLET's
bovine counterpart) and membrane-binding Peptide C, corresponding to
BLA residues 75–100, also form AO-like structures under these conditions
but at higher subphase concentrations than HAMLET. The N-terminal
Peptide A, which binds to membranes at acidic but not at neutral pH, did
not form AOs. This suggests a correlation between the capacity of the
proteins/peptides to integrate into themembrane at neutral pH—as observed
by liposome content leakage and circular dichroism experiments—and
the formation of AOs, albeit at higher concentrations. Formation of AOs,
which might be important to HAMLET's tumor toxic action, appears
related to the increased tendency of the protein to populate intermediately
folded states compared to the native protein, the formation of which is
promoted by, but not uniquely dependent on, the oleic acid molecules
associated with HAMLET.© 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.z is to be contacted at Department of Biomedicine, Jonas Lies vei 91, 5009 Bergen,
Gate 55, 5008 Bergen, Norway. E-mail addresses: aurora.martinez@biomed.uib.no;
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91HAMLET Forms Annular OligomersIntroduction
Within the standard pharmacological framework,
emphasis is put on the action of drugs via activation
of receptors; the drug elicits a discrete conforma-
tional change in the receptor that triggers a cellular
signaling response that, in turn, has the intended
medical effect. While the success and explanatory
power of the receptor-focused paradigm is very real,
there exist a number of independent reports on
prospective protein and peptide-based therapeutics
that do not easily ﬁt into this framework. The fungal
ribotoxin protein α-sarcin has cytotoxic and anti-
cancer properties that are thought to be mediated
mainly through interaction with the plasma mem-
brane, independently of receptors and endocytosis
pathways.1–3 As is well established, many pharma-
ceutically interesting peptides also work through
perturbation of membrane integrity,4–8 and these
are under intense scrutiny for their cytotoxic action
on cancer cells, as well as for their antibiotic
properties.6,9–12 What both protein and peptide
phenomena have in common is that they imply an
afﬁnity for membranes that is invariably enhanced
by the presence of negatively charged bilayer
components.2
A promising candidate for a membrane-targeting
therapeutic is human α-lactalbumin (α-La) made
lethal to tumor cells (HAMLET).13,14 This protein–
oleic acid complex selectively kills a broad range of
tumor cell lines,13,15 and its pharmacological poten-
tial has been successfully realized in clinical
trials.16,17 From a folding perspective, the HAMLET
conformer is also very interesting. It resembles the
α-La molten globule folding intermediate,18 which
has been characterized in detail for both the
bovine19 and the human20 varieties, and appears
to be locked in this conﬁguration by the oleic acid
«cofactors» that are needed for activity.21 A broad
range of effects is seen in the cell as HAMLET
rapidly kills susceptible targets. HAMLET is
reported to accumulate in the nucleus, to interact
with histones,22,23 mitochondria,24 lysosomes25 and
proteasomes.26 While cell death mediated by HAM-
LET shows some hallmarks of apoptosis, including
loss of membrane potential and phosphatidylserine
exposure in the membrane,21,27 the apoptotic
process is not slowed by caspase inhibition or
overexpression of Bcl-2.27,28 Recently, elevated
expression levels of c-Myc, an oncogene that binds
to a signiﬁcant fraction of all known gene promoters,
were identiﬁed as determinants for HAMLET-
sensitive phenotypes. Cells with elevated c-Myc
levels are sensitive to HAMLET, and short hairpin
RNA-mediated knockdown of the c-Myc gene
desensitizes normally susceptible cells to treat-
ment.29 Despite this discovery, questions regarding
HAMLET's mechanism of action remain unan-
swered, including details of the initial HAMLET–cellinteraction and how the sensitive phenotype
differs from the resistant in this and subsequent
steps. The individual roles of the protein and oleic
acid components in causing cell death are also
unclear.
An interesting quality of HAMLET is its ability to
bind to and at the same time perturb bilayers, cell
remnants and whole cells under physiological
conditions.30 α-La, in contrast, binds weakly to
tumor cells and causes little further effect on the
outer membrane or cell viability.21 We have recently
shown that, compared with bovine α-La (BLA),
HAMLET causes increased leakage of vesicle
contents at neutral pH, in parallel with its increased
membrane binding ability.30 This increased afﬁnity
of HAMLET for membranes appears important to
understand its selectivity, cellular import and cause
of cell death, although the particular mechanism for
membrane destabilization lacks detail. We here
show by atomic force microscopy (AFM) that,
under physiological conditions, HAMLET readily
distorts the lipid monolayer at very low concentra-
tions (7 ng/mL) and pore-like oligomeric structures
in lipid monolayers at higher concentrations. The
pores resemble annular oligomers (AOs), toxic
aggregate states described in other protein systems
under scrutiny for their role in disease.31,32 Further,
BLA produces essentially the same pore-like AOs,
but effective protein concentrations higher than
those for HAMLET are required. Moreover, one
out of two peptides derived from BLA membrane
binding motifs caused leakage and formed similar
pores at elevated peptide concentrations. These
ﬁnding emphasize the enhancement of intrinsic
properties of the α-La polypeptide chain in HAM-
LET, coupled to a local weakening of the membrane.Results
Membrane distortions and formation of AOs by
HAMLET studied by AFM
In order to investigate the mechanism and details
of membrane disruption, we explored the mem-
brane interaction of the active, oleic-acid-associated
HAMLET by AFM. The protein was co-deposited
using the Langmuir–Blodgett technique onto mica
chips with lipid monolayers consisting of a zwitter-
ionic extract, egg yolk phosphatidylcholine (EYPC),
mixed 1:1 with a negatively charged phospholipid
extract, porcine brain phosphatidylserine (PBPS), a
composition referred to as EYPC:PBPS. This mix is
considered a good mimic of negatively charged
physiologically relevant membranes.30,33
Deposition of mixed polypeptide–lipid monolayer
ﬁlms on hydrophilic mica results in an orientation of
the lipid head groups toward the mica surface.34
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be trapped between the mica and the lipid mono-
layers or, alternatively, intercalated in the lipid ﬁlm.
Throughout the study, reference AFM images of
mica only exposed to polypeptide-containing sub-
phase in the Langmuir tray (Fig. S1a) and lipid
monolayers deposited in the absence of polypeptide
were prepared and in all instances produced no
distortions (Fig. S1b). We investigated the effect of
HAMLET on monolayer topology at neutral pH,
where HAMLET is biologically active. As seen by
surface plasmon resonance and vesicle leakage
content experiments, HAMLET strongly binds to
immobilized large unilamellar vesicles (LUVs) at
low protein concentrations.30 We observed mem-
brane distortions that formed readily at subphase
concentrations as low as 7 ng/mL (Fig. 1c) and built-
up in the monolayers in a dose-dependent manner
(Fig. 1c, e and g). At the highest HAMLET subphase
concentration (142 ng/mL; Fig. 1i), additional and
larger distortions of approximately 4 nm in height
relative to the lipid ﬁlm baseline appeared. These
structures typically spanned 100–300 nm, were
evenly distributed in the monolayer and were
characterized by a depression down to the image
baseline in their centre. The distortions are immedi-
ately suggestive of AOs, polypeptide structures
forming pores in membranes.32,35 Such pores are
reported to form from disordered and usually
aggregated protein states and show a large range
of dimensions, from around 20 nm35,36 to 70–
90 nm35,37 and 100–250 nm.32 The latter pore size,
very similar to that obtained here for HAMLET-
induced distortions (Fig. 1i), was reported in an
AFM investigation of α-synuclein on protein–lipid
monolayer ﬁlms, where the occurrence of the AOs
was also linked to membrane destabilization.31
Ability of native BLA to influence the monolayer
compared to HAMLET
We then investigated the interaction of native BLA
with EYPC:PBPS monolayers by AFM at pH 5.0,
where BLA binds to membranes with high afﬁnity.
Under these conditions and at a subphase polypep-
tide concentration of 43 ng/mL, both HAMLET and
BLA caused distortions of the monolayer (Fig. 1a
and b, respectively), which were smaller than those
observed for HAMLET at neutral pH, and did not
have the characteristic AO topology found under
neutral conditions. Under acidic conditions, BLA
and HAMLET showed similar effects on the
monolayer with respect to afﬁnity and topological
changes. At neutral pH values, where the afﬁnity of
the native protein is much lower,30,38 we also
observed concentration-dependent AO formation
by BLA (Fig. 1d, f and h). As was the case for
HAMLET at the lowest concentration (7 ng/mL),
the effect induced by BLA on the monolayer waslimited to smaller (b40 nm) distortions (Fig. 1c and
d). These might be AO precursors, as reported prior
to the formation of AOs by other proteins.35 To
verify that the bovine HAMLET counterpart (pre-
pared using BLA), that is, BAMLET, also has the
ability to form AOs at comparable concentrations,
we performed the same experiments using BAM-
LET, both at 43 ng/mL and at 142 ng/mL. Indeed,
BAMLET also formed AOs, albeit at slightly
attenuated efﬁciencies (Fig. S2). The results with
HAMLET, BAMLET and BLA thus indicate that AO
formation is an intrinsic property of the polypeptide
chain that is enhanced—but not dependent on—
complexation with oleic acid (the fatty acid compo-
nent of HAMLET).
Ability of Peptide A and Peptide C to influence
the lipid monolayer
To test whether there are segments of the protein
that contribute to the formation of AOs, we also
studied the effect of Peptides A and C, correspond-
ing to helices A (residues 1–18) and C (residues 75–
100) in BLA (Fig. 2). We have previously identiﬁed
these segments as structural determinants involved
in the reversible, pH-dependent membrane binding
of BLA.39 At pH 5.0, conditions where the native
apoprotein binds with high afﬁnity,38 3 nM Peptides
A (7 ng/mL) and C (9 ng/mL), did not perturb the
membrane to the same extent as equimolar concen-
trations of HAMLET and BLA at pH 5.0 (Fig. S1c
and d). Under these conditions, the peptide-induced
effect on the monolayer is again limited to the
smaller (b20 nm) distortions of low incidence,
notably for Peptide C (Fig. S1d).
Since it appears that the formation of AOs in lipid
monolayers is promoted in a dose-dependent
manner at neutral pH (Fig. 1), we proceeded to
examine the effect of the peptides under neutral
conditions and at highly elevated subphase concen-
trations compared with those used with HAMLET
and BLA. This was justiﬁed as the peptides induced
some monolayer perturbations (Fig. S1c and d),
similar to those observed for both BLA and
HAMLET at lower subphase concentrations. Also,
small peptides are less surface active overall than
full-length proteins.40 At 10 nM concentrations, both
peptides (22 ng/mL for Peptide A and 30 ng/mL for
Peptide C) perturbed the monolayer to some extent
(Fig. 3a and b) but failed to form AOs. At subphase
concentrations of 200 nM, we observed AO forma-
tion in the case of Peptide C (591 ng/mL; Fig. 3d and
inset). Clearly, the propensity for AO formation is
much lower than for the full-length protein but still
present to some degree. Peptide A showed no AO
formation in monolayers even at 200 nM (440 ng/
mL; Fig. 3c). Both helices A and C are implicated in
membrane binding,39 and we were thus interested
in determining whether the two corresponding
Fig. 1. AFM images acquired on
tapping mode of HAMLET (left
column) and BLA (right column)
deposited with EYPC:PBPS mono-
layers on mica chips. HAMLET (a)
and BLA (b) prepared at 3 nM
subphase concentration, pH 5.0.
(c–h) EYPC:PBPS monolayers and
either HAMLET (c, e and g) or BLA
(d, f and h) prepared at pH 7.4,
subphase protein concentrations at
7 ng/mL, 43 ng/mL and 142 ng/
mL (0.5 nM, 3 nM and 10 nM),
respectively. (i) 3D representation
of an AO formed by HAMLET in an
EYPC:PBPS monolayer.
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Fig. 2. Helical wheel projections
of (a) Peptide A (residues 1–18
from BLA) and (b) Peptide C
(residues 75–100 from BLA).
Amino acids are denoted using
their standard one-letter abbrevia-
tions. Positively charged residues
are colored green; negatively
charged residues, magenta; polar
residues, blue; glycines, red; and
hydrophobic residues, light ochre.
The schematic representations of
BLA inside the wheels highlight
(in yellow) the position of the
corresponding A (a) and C (b)
peptides in the 3D structure of
BLA. Helices are labeled A, B, C and D, as well as a short 310-helix, reading from the N-terminus to the C-terminus
of the protein.
Fig. 3. AFM images acquired on
tapping mode of Peptide A (left
column) and Peptide C (right col-
umn) and Peptides A and C com-
bined (center bottom) deposited
with EYPC:PBPS monolayers on
mica chips. Peptide A (a) and
Peptide C (b) at pH 7.4, 22 ng/mL
and 29 ng/mL subphase concentra-
tions, respectively (10 nM). Peptide
A (c) and Peptide C (d) at pH 7.4,
440 ng/mL and 589 ng/mL sub-
phase concentrations, respectively
(200 nM). Inset: scale bar represents
100 nm. (e) Peptide A and Peptide C
at 100 nM subphase concentration
(for each peptide, total peptide
mass is 515 ng/mL), pH 7.4. Inset:
scale bar represents 100 nm.
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formation and monolayer perturbation. As can be
seen (Fig. 3e), the peptides added together in
equimolar amounts formed a signiﬁcant amount of
distortions but no clear AOs (515 ng/mL, 200 nM
total peptide concentration).
Destabilization of the membrane by HAMLET,
BLA, Peptide A and Peptide C
Taken together, the results above show that
HAMLET, BLA and Peptide C form pore-like
structures that, in other systems, have been associ-
ated with cytotoxic activity. Formation of these
structures requires binding, accumulation and ag-
gregation at the membrane. HAMLET shows the
highest ability to generate these structures at very
low concentrations, but in fact, BLA was also
effective. Previous investigations from us and others
have shown that, at neutral pH, BLA has low afﬁnity
for membranes, both negatively charged and
zwitterionic.41,42 There are, however, some reports
that BLA and the human variety bind weakly to cell
membranes30 and to some model membranes43 at
neutral pH. We therefore comparatively reinvesti-
gate the membrane binding of the proteins and asses
the binding of the peptides. We have recently shown
a good correlation between the concentration
dependencies for the adsorption to bilayers—as
measured by surface plasmon resonance—and
induction of leakage content to liposomes, for both
BLA and HAMLET.30 Leakage is caused by the
perturbation of the hydrophobic core of the bilayer
by the protein.38,42,44 The assay of membrane
disruption by the 8-aminonaphtalene-1,3,6-trisulfo-
nic acid (ANTS)/p-xyelene-bis-N-pyrimidium bro-
mide (DPX) leakage ﬂuorescence assay thus
represents a simple way to estimate binding coupled
to membrane perturbation. We investigated the
efﬁciency of HAMLET, BLA, Peptide A and Peptide
C in inducing leakage of liposome content by using
LUVs prepared from EYPC:PBPS with encapsulated
ANTS/DPX and monitored the ANTS ﬂuorescence
in response to increasing amounts of proteins and
peptides.30,45 BLA and HAMLET destabilized the
bilayers under acidic conditions (∼ pH 5) at similar
concentrations (Fig. 4a). Moreover, Peptide C
accounted for ∼50% leakage relative to the full-
length, native protein, while Peptide A caused
negligible leakage (Fig. 4a).
At neutral pH (Fig. 4b), both BLA and peptides
caused some leakage, although effective concentra-
tions much higher than those for HAMLET were
needed (Fig. 4b). Peptide C was again particularly
effective, and under neutral conditions, it caused
higher content release than the native protein, while
Peptide A showed a low ability to disrupt the
vesicles. Thus, we conclude that helix C (corre-
sponding to Peptide C; see Fig. 2b) is important forthe overall membrane-disruptive properties of BLA
and most probably HAMLET (sequence identity for
this peptide section between human and BLA is
84.6%). As in the case of the AFM experiments,
attempts to evaluate a possible concerted action of
the peptides in leakage promotion by simultaneous
addition of both peptides did not provide conclusive
evidence for synergy (Fig. 4). Although the binding
and membrane disruption of HAMLET cannot be
explained in terms of the properties of the two
peptides—since they cannot account for HAMLET
ability to cause the extent of vesicle disruption at
neutral pH and low concentrations—it was inter-
esting that Peptide C can both cause leakage at
elevated concentrations and form AOs. We thus
proceeded to explore the conformational propensi-
ties of this peptide in membrane-mimicking systems
compared to Peptide A.
Membrane binding and destabilization
associated with high propensity for
helix formation
We compared the propensity of Peptides A and C
to adopt secondary structure as they interact with
liposomes at pH 5.0, where interaction with the
membrane is effective (Fig. 4a). As seen by circular
dichroism (CD) and secondary structure estimation
by neural network analysis,46 both peptides formed
helices upon binding (Fig. 5a and b), as is usual for
peptides interacting with membrane bilayers.47
Helix formation was more pronounced for Peptide
C, which at the endpoint of the titration was more
than 60% α-helical in the presence of LUVs made of
EYPC:PBPS (Fig. S3). The helix-forming abilities of
the peptides were further tested in triﬂuorethanol
(TFE), and this tendency was also found to be lower
for Peptide A compared to Peptide C. Peptide C
fulﬁlled most of its potential to form a helical
conﬁguration in this medium (Fig. 5d), suggesting
that its high helical propensity in response to
binding charged lipids—both in absolute terms
and compared to Peptide A and in TFE—may be
linked to a penetration into (and disruption of) the
membrane (Fig. 4).Discussion
AO formation by HAMLET, BLA and Peptide C
HAMLET is the most proliﬁc AO-forming poly-
peptide of those examined here and readily causes
leakage at very low concentrations. For Peptide C,
AOs appear at 200 nM (591 ng/mL) peptide
concentration in the subphase. At neutral pH,
there is in fact a good correlation between the ability
to cause leakage, which in turn correlates well with
Fig. 4. Disruption of membrane
integrity. Leakage of ﬂuorophore
(ANTS) and its quencher (DPX)
from LUVs made of EYPC:PBPS
induced by Peptide A (○), Peptide
C (●), Peptide A and C together
(□), BLA (△) and HAMLET (▲).
Brieﬂy, the dose-dependent in-
crease of ﬂuorescence at 510 nm
(excitation at 355 nm) is bench-
marked relative to unperturbed
LUVs (set to 0% leakage) and
LUVs disrupted by addition of
Triton X-100 (set to 100% leakage).
For details, see Materials and
Methods. (a) Leakage induced by
Peptide A and Peptide C at pH 5.0
compared to HAMLET and BLA.
(b) Leakage induced by Peptide A
and Peptide C at pH 7.0 compared
to HAMLET and BLA. Inset: leak-
age induced by HAMLET at 0–
16 μM concentration, from Moss-
berg et al.30
96 HAMLET Forms Annular Oligomersthe membrane binding afﬁnity of BLA and
HAMLET,30,41 and the appearance of AOs as seen
by AFM. Similar AOs are observable for both BLA
and HAMLET at neutral pH and low concentrations
(3–10 nM, 43–142 ng/mL protein concentration in
the subphase). Thus, the very high HAMLET ability
to interact with membranes and form pores under
physiological conditions could be interpreted as a
propensity already present in the bovine and human
α-La polypeptide chains that is enhanced by the
oleic acid component in the complex. An important
step in the membrane binding of BLA is the
loosening of the protein tertiary structure,41 which
is facilitated by the proton gradient near the
membrane and marginal folding barrier of
BLA.38,39,48 This step would not be required for
HAMLET, which is already loosely folded.21 Other
proteins that also form AOs upon membrane
association are intermediately folded as well.32,49
HAMLET was ﬁrst reported to be multimeric,13 and
BLA also appears to form multimers under condi-tions known to promote the population of interme-
diate folds. 50,51 Thus, conditions that drive
membrane binding, with a signiﬁcant associated
disturbance of the monolayer as seen by leakage
experiments, also appear to be strong drivers for the
formation of AOs and vice versa. Moreover, oligo-
merization reaction rates are concentration
dependent,52 and as a protein migrates from bulk
[three dimensional (3D)] to the membrane (approx-
imately two-dimensional array), there is a great
effective increase in the protein concentration.53
Conceivably, if a protein—or its multimeric form—
diffuses to a membrane domain border in the lipid
membrane, the membrane will experience a further
up-concentration of protein at a location where there
is a mismatch in structure and physical state
between the two domains. We propose that the
initial distortions and pore-like AO structures
observed by AFM may represent such a localized
up-concentration and spatial restriction of oligomer-
ic BLA/HAMLET (and BAMLET). HAMLET could,
Fig. 5. Structural changes in Peptides A and C upon membrane binding monitored by CD. CD spectra of Peptide A (a) and Peptide C (b) in the presence of
increasing amounts of LUVs made of EYPC:PBPS at pH 5.0. Phospholipid concentration was 0 mM (●), 0.17 mM ( ), 0.33 mM ( ), 0.50 mM ( ), 0.67 mM ( ) and
0.83 mM. CD spectra of Peptide A (c) and Peptide C (d) in increasing amounts of TFE at pH 5.0. TFE concentration was 0% (●), 4.8% ( ), 9.1% ( ), 13.0% ( ), 16.7% ( ),















98 HAMLET Forms Annular Oligomershypothetically, assemble preferentially at domain
borders and in this way facilitate pore formation. Of
possible relevance to this is the ﬁnding that both
HAMLET and BLA show a hitherto unexplained
enhanced activity when ∼1:1 mixes of negatively
charged and zwitterionic lipids are used to prepare
the vesicles for leakage assays.42 Earlier studies have
also indicated that bound BLA greatly inﬂuences the
TC and TC½ (the gel-to-liquid crystalline phase
transition temperature and transition half-width,
respectively) of lipid mixes while the effect on lipid
vesicles made of only one lipid is small.38 Langmuir
monolayer studies show that the miscibility of
EYPC:PBPS 1:1 mixes is low but can be altered by
adsorbing species.54
It is tempting to directly link disruptions in planar
monolayers and leakage in bilayer vesicle systems
(with an estimated available surface area per LUV of
125,000 nm2), but this cannot be performed in a
straightforward manner; any such interpretation
should be made with caution. There exist empiri-
cally determined relationships between the ability of
a protein to intercalate in a lipid monolayer and
leakage experiments, see in particular work by
Wijewickrama et al.55 Brieﬂy, leakage in the Wije-
wickrama study drops to zero if the protein mutants
cannot affect monolayers precompressed to lateral
pressures of about 30mN/m. Themonolayers in this
study were not precompressed, but we observed
extensive leakage, strongly indicating HAMLET's
ability to intercalate into monolayers also at elevated
lateral pressures. As used here and based on
previous studies,30,44 leakage can be applied to
comparatively monitor the binding of the proteins/
peptides to the membrane, a binding that is not
necessarily accompanied by irreversible aggregation
of the protein. Thus, as we have previously shown,
the peripheral binding of BLA to membranes can be
reverted by, for instance, pH changes, providing the
soluble conformation of the protein,38,39 and leakage
might be a functionalmanifestation of themembrane
disruptions observed at very low amounts of the
proteins on the uncompressed monolayers (Fig. 1a
and b). These disruptions might function as nucle-
ation sites for further accumulation and aggregation
of the protein in AOs, which will lead to complete
and irreversible disruption of the vesicle system.
Although pores in general are often formed by
helical motifs,56 available data for other systems
have indicated that AO structures are dominated by
polypeptide in β-sheet conformation.37 The domi-
nantly helical secondary structure of Peptide C and
BLA appears to be maintained upon membrane
binding (Fig. 5 and Refs. 38 and 44) but might be
further affected upon up-concentration and result-
ing aggregation. Discrete molecular dynamics have
revealed the transition from helical to β-sheet
conformation upon formation of annular protoﬁ-
brils made of amyloid-β oligomers. 57 Furtherstudies are thus necessary to elucidate the AOs
described in this work.
AO formation and cytotoxic activity of HAMLET
While HAMLET inﬂuences the permeability of
artiﬁcial membranes30 and increases ion ﬂuxes in
tumor cells,13,29,58 there is no evidence that AO
formation occurs in intact cells exposed to HAM-
LET. The ability of HAMLET to form AOs in
artiﬁcial lipid bilayers likely needs to be translated
into a more complex molecular context in intact
tumor cell membranes. In such membranes, HAM-
LET has recently been shown to activate speciﬁc
membrane channels in conjunction with signaling
pathways that determine death (C. Svanborg,
unpublished results). Beyond the plasma mem-
brane, HAMLET and HAMLET-like preparations
colocalize to the membranes of both lysosomes and
mitochondria in susceptible cells.24 In lysosomes,
HAMLET causes release of cathepsin, a marker for
loss of lysosomal membrane integrity.25 In mito-
chondria, HAMLET affects the integrity and mor-
phology of the mitochondrial membrane.24,59 Both
lysosomal and mitochondrial membrane permeabi-
lization are mutually reinforcing key events in cell
death, either as initiating or as amplifying effects.60
In many cases, both exogenous and endogenous
killing agents such as Bax, Bak and viral proteins
have been shown to form pores in both lysosomes
and mitochondria.60–62 Thus, the identiﬁcation of
HAMLET as an AO-forming protein complex could
also be related to action on organelle membranes,
and this may be a worthwhile line of investigation in
exploring the full effect of this complex. Further-
more, the present study clearly suggests that the
protein is critical for deﬁning the properties of the
HAMLET complex and that HAMLET does not act
merely by ofﬂoading oleic acid molecules into the
membrane, unlike ELOA (equine lysozyme multi-
meric complexes with oleic acids), which is a
preparation resembling HAMLET but with a large
excess of fatty acid molecules.63 The role of the oleic
acids would be both to increase the membrane
afﬁnity of the HAMLET nucleation sites and to
locally alter the membrane.Materials and Methods
Protein, peptides and other materials
Peptide A [E(1)QLTKCEVFRELKDLKGY(18)] and Pep-
tide C [I(75)SCDKFLDDDLTDDIMCVKKILDKVG(100)]
were obtained from CPC Scientiﬁc Inc., San Jose, CA, and
the numbers refer to positions in BLA. HAMLET complex
was formed from human (and, for the experiments in Fig.
S2, bovine) α-La and oleic acid, as described previously.21
BLA (UniProt identiﬁer: P00711|20-142), ANTS and DPX
99HAMLET Forms Annular Oligomerswere purchased from Sigma-Aldrich. PBPS and EYPC
were obtained from Avanti Polar Lipids (Alabaster, AL,
USA).Deposition of mixed protein–lipid monolayers on mica
surfaces
HAMLET, BLA and peptides were dissolved in a
buffer containing 5 mM citrate/10 mM Na2HPO4, either
pH 5.0 or 7.4. Depositions of lipid monolayers with and
without polypeptide present in the subphase were
carried out with a KSV Minitrough ﬁtted for monolayer
deposition (Helsinki, Finland) using the manufacturer's
software at 37 °C. The Teﬂon trough (75 mm×
364 mm×5 mm) was ﬁlled with protein- or peptide-
containing buffers at the corresponding pH. The poly-
peptide concentration given for each AFM experiment
corresponds to the amount of polypeptide added to the
through subphase volume (136.5 mL). Freshly cleaved
mica (Agar Scientiﬁc Ltd., England) was used as a
supporting solid substrate for the ﬁlm deposition
(dipping method). The mica was immersed in the trough
before spreading the phospholipid solution on the buffer
phase. The surface was swept, and the possible impuri-
ties were removed from the air/water interface with a
Pasteur pipette, prior to each experimental run. We
carefully spread 20 μL of glycerophospholipid in
chloroform (1 mg/mL) on the surface with a Hamilton
syringe, and the chloroform was allowed to evaporate
before starting the measurements. Compression of the
lipid monolayers was performed at 5 mm/min while an
electrobalance recorded the surface tension with a
Wilhelmy plate. The ﬁlm area was compressed to a
surface pressure of 30 mN/m and left for approximately
20 min for stabilization. The mica sheets were detached
and transferred to the AFM instrument for imaging.AFM imaging
AFM imaging was carried out in air at room temper-
ature using tapping mode (AC mode) on an MFP-3D-
Bio™ atomic force microscope (Asylum research). Silicon
cantilevers, ACL, from AppNano with a typical spring
constant of 48 N/m were used. Images were captured
with a size of 256×256 pixels, and the scan rate was
adjusted for each sample to a value between 0.5 and 1 Hz.Preparation of liposomes
The prerequisite amounts of chloroform-solved lipids
were transferred using a Hamilton glass syringe to Kimble
glass tubes wrapped in aluminum foil to reduce exposure
to light in subsequent steps. Lipid ﬁlms were produced
under dry N2 pressure, subjected to vacuum for at least 2 h
and hydrated in buffer overnight. For liposome prepara-
tion, the solutions were subjected to seven freeze–thaw
cycles using liquid N2 and a warm water bath.
64 Finally,
the hydrated multilamellar structures were extruded
using a LIPEX extruder (Northern Lipids), assembled
with two membrane ﬁlters (Whatman), pore size of
200 nm. The samples were forced through the ﬁlters 10
times using N2 pressures of 12 bar, producing LUVs.
65,66For the liposomes to be used in the ANTS/DPX leakage
experiments, the buffer used for hydrating the lipid ﬁlm
contained 12.5 mM ANTS and 45 mM DPX. The
unencapsulated ﬂuorophores and quenchers were re-
moved by gel ﬁltration on a Sephadex G-75 exchange
column.
Fluorescence-monitored leakage assays
Liposomes with ANTS/DPX encapsulation were dilut-
ed to 1 mM lipid concentration using citrate/Na2HPO4 at
either pH 5.0 or 7.0. We added 0.5 mL volumes to a
Hellma GmbH & Co. quartz cuvette with a 5-mm path
length, and we measured ﬂuorescence with a Perkin-
Elmer LS5 luminescence spectrometer. Volumes of stock
solutions of BLA, HAMLET or peptides were added
stepwise directly to the cuvette. To be able to compare
dilution and temporal effects such as spontaneous leakage
of liposome contents, we used volumes of water equiva-
lent to the volumes of the protein stocks. ANTS excitation
was performed at 355 nm, and emission was measured in
the range of 450–550 nm. The resulting spectra are
strongly dominated by the ANTS ﬂuorescence, with a
λmax at 510 nm. An increased intensity at this wavelength
indicates loss of liposome integrity as the average distance
between ANTS and DPX increases. After each titration,
Triton X-100 was added to a ﬁnal cuvette concentration of
2 mM. The resulting ﬂuorescence at 510 nmwas arbitrarily
set to 100%, that is, complete liposome breakdown.
Similarly, the ﬂuorescence at 510 nm prior to addition of
any stock solution or volume of water was arbitrarily set
to 0%, that is, no leakage.
Circular dichroism
CD experiments were performed in the far-UV spectral
range with a Jasco J-810 CD spectropolarimeter, typically
using continuous scanning at 50 nm/min. Appropriate
blanks were subtracted from each spectrum by using the
software provided by the instrument manufacturers. We
utilized 1.0-mm quartz cuvettes from Hellma. The
experiments were carried out at 25 °C, and for each
point, two scans were accumulated. The mean residue
ellipticity (θ) was determined using the formula θ=ɛ/
(10×C×n× l). Here, ɛ is the experimentally determined
ellipticity in millidegrees, l is the path length of the cuvette
(cm), C is the protein concentration (mol/L), 10 is a scaling
factor, and n is the number of amino acids, which is 18 and
26 for Peptide A and Peptide C, respectively. This formula
gives θ with units deg cm2 dmol−1.Acknowledgements
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